Synovics Pharmaceuticals, Inc. Appoints Steven Getraer as Executive Vice President and Chief Financial Officer

PHOENIX--(BUSINESS WIRE)--Synovics Pharmaceuticals, Inc., (OTCBB:SYVC) a specialty pharmaceutical company, today announced that Steven Getraer has been appointed Executive Vice President and Chief Financial Officer of Synovics, effective immediately. In this role Steven will be in charge of and responsible for financial management of the Company, including accounting and internal controls, treasury, financial planning, tax, investor relations, information systems and administrative functions. Since August 2006, Mr. Getraer has held the title of Chief Executive Officer of Kirk Pharmaceuticals, LLC, a wholly owned subsidiary of Synovics, working with the Company to develop a comprehensive growth strategy and operating plan.

Back to news